Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.488 SEK | -3.75% | -2.40% | +6.90% |
22/05 | Active Biotech Secures Exclusive Licensing Rights to Multiple Myeloma Drug | MT |
08/05 | Active Biotech AB Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
- Stock Market
- Equities
- ACTI Stock
- Charts Active Biotech AB
- Static Chart